EPOGENĀ®

Generic Name: Epoetin alfa
Study IDStudied Indication or DiseasePhaseStudy TitleSynopsis
20040259Treatment of anemia in patients with chronic kidney disease (CKD) not on dialysis3A Randomized, Open-Label Study to Assess the Safety of Epoetin Alfa Manufactured by Deep Tank Technology and Epoetin alfa Manufactured by Roller Bottle Technology in Subjects with Chronic Kidney Disease Not on Dialysis
20040268Treatment of anemia in patients with chronic kidney disease (CKD) receiving dialysis (hemodialysis or peritoneal dialysis)3

An Open-Label, Single-Arm Study to Assess the Safety of Epoetin Alfa Manufactured by a Deep Tank Technology in Subjects with Chronic Kidney Disease Receiving Dialysis

20050113Treatment of anemia in patients with chronic kidney disease (CKD) receiving hemodialysis3A Randomized, Double-Blind, Equivalence Study of the Efficacy of Epoetin Alfa Manufactured by Deep Tank Bioreactor Technology and Epoetin Alfa Manufactured by Roller-Bottle Technology for the Treatment of Anemia in Patients with Chronic Kidney Disease Receiving Hemodialysis
20110209Treatment of anemia in subjects with chronic kidney disease receiving hemodialysis4Evaluation of the Conversion From Peginesatide to Epoetin alfa in Subjects Receiving Hemodialysis